|
Re: I think one major reason that,
|
3
|
Resverlogix Corp.
|
Nov 01, 2019 04:33PM
|
|
Re: eGFR data question from IR
|
3
|
Resverlogix Corp.
|
Nov 26, 2019 05:23PM
|
|
Re: BETonMACE Placebo Estimate Crestor/Lipitor.....
|
3
|
Resverlogix Corp.
|
Feb 19, 2019 09:53PM
|
|
Re: BETonMACE Placebo Estimate
|
3
|
Resverlogix Corp.
|
Feb 23, 2019 10:30AM
|
|
Re: Update
|
3
|
Resverlogix Corp.
|
Jun 12, 2019 12:12PM
|
|
Re: My guess is a second BTD is coming
|
3
|
Resverlogix Corp.
|
Feb 08, 2020 10:35AM
|
|
Re: No love
|
3
|
Resverlogix Corp.
|
Dec 13, 2018 12:55PM
|
|
Re: Odd About The Disappearing Presentation
|
3
|
Resverlogix Corp.
|
May 21, 2017 11:14PM
|
|
Re: Third Eye, AHA, US Listing
|
3
|
Resverlogix Corp.
|
Sep 11, 2019 03:55PM
|
|
BETonMACE USA vs. non-USA brainstorming
|
3
|
Resverlogix Corp.
|
Nov 20, 2017 05:40PM
|
|
Re: BTI:TSXV; BIOAF:OTCQB: "Announces Rare Diseases Strategic Alliance With Chiesi"
|
3
|
BIOASIS TECHNOLOGIES INC
|
Jun 29, 2020 04:16PM
|
|
Re: Resverlogix’s BETonMACE Phase 3 Epigenetics Trial Completes Final Safety Visits
|
3
|
Resverlogix Corp.
|
Jul 08, 2019 09:54AM
|
|
Re: ZEN003694 Trial Now Listed on ClinicalTrials.gov
|
3
|
Zenith Epigenetics
|
Mar 12, 2016 02:09PM
|
|
Re: Zenith Abstract at AACR 2017 Meeting April 1-5
|
3
|
Zenith Epigenetics
|
Apr 03, 2017 01:38PM
|
|
Re: Total Patient Hours Question
|
3
|
Resverlogix Corp.
|
Sep 17, 2019 10:25PM
|
|
Resverlogix Proudly Announces Funding for Phase 2 Trial Evaluating Apabetalone in PAH
|
3
|
Resverlogix Corp.
|
Mar 18, 2019 01:06PM
|
|
RVX TO HOST R&D UPDATE FEATURING KEY OPINION LEADERS IN CVD AND RENAL DISEASE
|
3
|
Resverlogix Corp.
|
Oct 04, 2016 09:25AM
|
|
Re: AGM....DND
|
3
|
Resverlogix Corp.
|
Sep 13, 2018 08:10AM
|
|
Re: Top scientific things that indicate that BETonMACE will be successful
|
3
|
Resverlogix Corp.
|
Feb 08, 2019 02:33PM
|
|
Re: Hepalink
|
3
|
Resverlogix Corp.
|
Feb 21, 2020 02:27PM
|
